Holen Sie sich die Stockscreener-App
17.95
0.66%
-0.12
Handel nachbörslich:
17.95
Schlusskurs vom Vortag:
$18.07
Offen:
$18.06
24-Stunden-Volumen:
2.14M
Relative Volume:
0.70
Marktkapitalisierung:
$4.27B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
21.14
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
+0.39%
1M Leistung:
-9.34%
6M Leistung:
-2.13%
1J Leistung:
-3.29%
1-Tages-Spanne:
$17.86
$18.19
1-Wochen-Bereich:
$17.65
$18.95
52-Wochen-Spanne:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
17.95 | 4.30B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Can ADMA Biologics Inc. stock beat analyst upgrades2025 Earnings Impact & Proven Capital Preservation Tips - ulpravda.ru
How ADMA Biologics Inc. stock valuations compare to rivalsDividend Cut Warnings & Fast Profit Trading Tips - ulpravda.ru
Published on: 2026-01-07 18:06:07 - ulpravda.ru
2026 world cup team news comparison: Will ADMA Biologics Inc. stock outperform growth indexes2026 world cup usa national team semifinals goalkeepers counter attacking tactical prediction preview - ulpravda.ru
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation As J.P. Morgan Healthcare Conference Presentation Nears - Sahm
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - The Manila Times
Why (ADMA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 1,772,112 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics IncCommon Stock (NQ: ADMA - FinancialContent
ADMA Biologics Inc $ADMA Shares Sold by Calamos Advisors LLC - MarketBeat
Does Kizi Apparels Limited Have a Competitive Advantage in Its SectorREITs Market Trends & Free Popular Stock Picks Selection - earlytimes.in
ADMA Biologics Earnings Notes - Trefis
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade - ts2.tech
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
Harbor Capital Advisors Inc. Buys Shares of 59,801 ADMA Biologics Inc $ADMA - MarketBeat
Rice Hall James & Associates LLC Has $4.75 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - MSN
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
High Growth Tech Stocks To Watch In US December 2025 - simplywall.st
The Bull Case For ADMA Biologics (ADMA) Could Change Following Its Higher 2025 Revenue Outlook Revision - Sahm
Adma Biologics Receives Upgraded Price Target on Strong Outlook - AD HOC NEWS
Assessing ADMA Biologics (ADMA) Valuation After Its Upgraded 2025 Revenue Guidance - Sahm
ADMA Biologics (ADMA): Firm updates 2025 revenue guidance - MSN
ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC - MarketBeat
Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance - Finviz
Should You Be Adding ADMA Biologics (NASDAQ:ADMA) To Your Watchlist Today? - Yahoo Finance
Fed Meeting: Will ADMA Biologics Inc. stock outperform growth indexes2025 Pullback Review & Long-Term Growth Stock Strategies - Улправда
Published on: 2025-12-21 05:20:22 - Улправда
Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
Jobs Data: How ADMA Biologics Inc. stock valuations compare to rivalsPortfolio Gains Report & Advanced Technical Analysis Signals - Улправда
Will ADMA Biologics Inc. stock gain from lower inflationJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - DonanımHaber
Published on: 2025-12-19 13:57:53 - Улправда
Decliners Report: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Winners & Losers & Low Risk High Reward Ideas - DonanımHaber
Can ADMA Biologics Inc. stock sustain revenue growthWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
CEO Grossman Sells 21,000 ($415.6K) Of Adma Biologics Inc [ADMA] - TradingView — Track All Markets
ADMA Biologics (ADMA) CEO trades stock under Rule 10b5-1 plan - Stock Titan
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - MSN
Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Does ADMA’s Upgraded EPS Outlook And Higher-Yield Manufacturing Change The Bull Case For ADMA Biologics (ADMA)? - Sahm
ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P. - MarketBeat
Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Precision Trading with Adma Biologics Inc (ADMA) Risk Zones - Stock Traders Daily
ADMA Biologics Inc $ADMA Holdings Decreased by AWM Investment Company Inc. - MarketBeat
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - MSN
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management - MarketBeat
Federated Hermes Inc. Has $17.06 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Dec 15 '25 |
Sale |
19.79 |
21,000 |
415,590 |
2,007,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,034,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,013,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,040,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,019,850 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):